Oral vaccination of dogs with recombinant rabies virus vaccines

Virus Research

Volumn 111, Issue 1, 2005, Pages 101-105

  Rupprecht, Charles E ^a   Hanlon, Cathleen A ^a   Blanton, Jesse ^a   Manangan, Jamie ^a   Morrill, Patricia ^a   Murphy, Staci ^a   Niezgoda, Michael ^a   Orciari, Lillian A ^a   Schumacher, Carolin L ^b   Dietzschold, Bernhard ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Canine vaccination; Oral vaccination; Rabies; Rabies vaccination; Rabies virus

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES IMMUNOGLOBULIN; RABIES VACCINE; UNCLASSIFIED DRUG; VACCINIA RABIES GLYCOPROTEIN RECOMBINANT VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFICACY; DRUG SAFETY; FEMALE; IMMUNOGENICITY; MALE; MASSETER MUSCLE; NONHUMAN; PRIORITY JOURNAL; RABIES; RABIES VIRUS; VACCINATION; VACCINIA VIRUS; VIRUS RECOMBINANT;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, DOMESTIC; DOGS; RABIES; RABIES VACCINES; RECOMBINANT PROTEINS; VACCINES, SYNTHETIC; ZOONOSES;

ANIMALIA; CANIS FAMILIARIS; MAMMALIA; RABIES VIRUS; VACCINIA; VACCINIA VIRUS;

EID: 21144451217     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2005.03.017     Document Type: Article

References (40)

1. M.F.A. Aubert, E. Masson, M. Artois, and J. Barrat Oral rabies vaccination field trials in Europe, with recent emphasis on France C.E. Rupprecht B. Dietzschold H. Koprowski Lyssaviruses. Current Topics in Microbiology and Immunology 1994 Springer-Verlag Berlin 219 243
2. J. Bingham, C.M. Foggin, H. Gerber, F.W. Hill, A. Kappeler, A.A. King, B.D. Perry, and A.I. Wandeler Pathogenicity of SAD rabies vaccine given orally in chacma baboons (Papio ursinus) Vet. Rec. 131 1992 55 56
3. J. Blancou, M. Artois, B. Brochier, I. Thomas, P.P. Pastoret, P. Desmettre, B. Languet, and M.P. Kieny Safety and efficacy of an antirabies vaccine consisting of recombinant vaccinia-rabies virus administered orally to the fox, dog and cat Ann. Rech. Vet. 20 1989 195 204
4. K.K. Conzelmann, and M. Schnell Rescue of synthetic genomic RNA analogs of rabies virus by plasmid-encoded proteins J. Virol. 68 1994 713 719
5. J.L. Corn, J.R. Mendez, and E.E. Catalan Evaluation of baits for delivery of oral rabies vaccine to dogs in Guatemala Am. J. Trop. Med. Hyg. 69 2003 155 158
6. J.H. Cox, B. Dietzschold, and L.G. Schneider Rabies virus glycoprotein. II. Biological and serological characterization Infect. Immun. 16 1977 754 759
7. B. Dietzschold, W.H. Wunner, T.J. Wiktor, A.D. Lopes, M. Lafon, C.L. Smith, and H. Koprowski Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus Proc. Natl. Acad. Sci. U.S.A. 80 1983 70 74
8. B. Dietzschold, and M.J. Schnell New approaches to the development of live attenuated rabies vaccines Hybrid Hybridomics 21 2002 129 134
9. B. Dietzschold, M. Faber, and M.J. Schnell New approaches to the prevention and eradication of rabies Expert Rev. Vaccines 2 2003 399 406
10. R. Estrada, A. Vos, R. De Leon, and T. Mueller Field trial with oral vaccination of dogs against rabies in the Philippines BMC Infect. Dis. 1 2001 23
11. M. Faber, R. Pulmanausahakul, S.S. Hodawadekar, S. Spitsin, J.P. McGettigan, M.J. Schnell, and B. Dietzschold Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response J. Virol. 76 2002 3374 3381
12. M. Fekadu, S.L. Nesby, J.H. Shaddock, C.L. Schumacher, S.B. Linhart, and D.W. Sanderlin Immunogenicity, efficacy and safety of an oral rabies vaccine (SAG-2) in dogs Vaccine 14 1996 465 468
13. N. Haddad, R. Ben Khelifa, H. Matter, H. Kharmachi, M.F. Aubert, A. Wandeler, and J. Blancou Assay of oral vaccination of dogs against rabies in Tunisia with the vaccinal strain SADBern Vaccine 12 1994 307 309
14. S. Hammami, C. Schumacher, F. Cliquet, A. Tlatli, A. Aubert, and M. Aubert Vaccination of Tunisian dogs with the lyophilised SAG2 oral rabies vaccine incorporated into the DBL2 dog bait Vet. Res. 30 1999 607 613
15. H. Koprowski The mouse inoculation test F.-X. Meslin M.M. Kaplan H. Koprowski Laboratory Techniques in Rabies fourth ed. 1996 World Health Organization Geneva 80 87
16. C.D. MacInnes, S.M. Smith, R.R. Tinline, N.R. Ayers, P. Bachmann, D.G. Ball, L.A. Calder, S.J. Crosgrey, C. Fielding, P. Hauschildt, J.M. Honig, D.H. Johnston, K.F. Lawson, C.P. Nunan, M.A. Pedde, B. Pond, R.B. Stewart, and D.R. Voigt Elimination of rabies from red foxes in eastern Ontario J. Wildl. Dis. 37 2001 119 132
17. F.-X. Meslin, D.B. Fishbein, and H.C. Matter Rationale and prospects for rabies elimination in developing countries C.E. Rupprecht B. Dietzschold H. Koprowski Lyssaviruses. Current Topics in Microbiology and Immunology 1994 Springer-Verlag Berlin 1 26
18. K. Morimoto, J.P. McGettigan, H.D. Foley, D.C. Hooper, B. Dietzschold, and M.J. Schnell Genetic engineering of live rabies vaccines Vaccine 19 2001 3543 3551
19. L.A. Orciari, M. Niezgoda, C.A. Hanlon, J.H. Shaddock, D.W. Sanderlin, P.A. Yager, and C.E. Rupprecht Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination Vaccine 19 2001 4511 4518
20. M.A. Perera, P.A. Harischandra, O. Wimalaratne, and S.N. Damboragama Feasibility of canine oral rabies vaccination in Sri Lanka-a preliminary report Ceylon Med. J. 45 2000 61 64
21. C.L. Preve, J.B. Campbell, B.S. Christie, L. Belbeck, and F.L. Graham A recombinant human adenovirus vaccine against rabies J. Infect. Dis. 161 1990 27 30
22. R. Pulmanausahakul, M. Faber, K. Morimoto, S. Spitsin, E. Weihe, D.C. Hooper, M.J. Schnell, and B. Dietzschold Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity J. Virol. 75 2001 10800 10807
23. R.E. Rohde, S.U. Neill, K.A. Clark, and J.S. Smith Molecular epidemiology of rabies epizootics in Texas Clin. Diagn. Virol. 8 1997 209 217
24. C.E. Rupprecht, B. Dietzschold, J.B. Campbell, K.M. Charlton, and H. Koprowski Consideration of inactivated rabies vaccines as oral immunogens of wild carnivores J. Wildl. Dis. 28 1992 629 635
25. C.E. Rupprecht, J.S. Shaddock, D.W. Sanderlin, C.A. Hanlon, M. Niezgoda, and C.L. Schumacher Oral rabies vaccination of dogs Isr. J. Vet. Med. 34 1998 228 239
26. C.E. Rupprecht, L. Blass, K. Smith, L.A. Orciari, M. Niezgoda, S.G. Whitfield, R.V. Gibbons, M. Guerra, and C.A. Hanlon Human infection due to recombinant vaccinia-rabies glycoprotein virus N. Engl. J. Med. 345 2001 582 586
27. M.J. Schnell, T. Mebatsion, and K.K. Conzelmann Infectious rabies viruses from cloned cDNA EMBO J. 13 1994 4195 4203
28. C.L. Schumacher, P. Coulon, F. Lafay, J. Benejean, M.F.A. Aubert, J. Barrat, A. Aubert, and A. Flamand SAG2 oral rabies vaccine Onderspoort J. Vet. Res. 60 1993 459 462
29. Slate, D., Chipman, R.B., Rupprecht, C.E., DeLiberto, T., 2002. Oral rabies vaccination: a national perspective on program development and implementation. In: Timm R.M., Schmidt, R.H. (Eds.), Proceedings of the 20th Vertebrate Pest Conference. Davis, University of California Press, pp. 232-240.
30. J.S. Smith, P.A. Yager, and G.M. Baer A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus neutralizing antibody F.-X. Meslin M.M. Kaplan H. Koprowski Laboratory Techniques in Rabies fourth ed. 1996 World Health Organization Geneva 181 192
31. K. Stohr, and F.M. Meslin Progress and setbacks in the oral immunisation of foxes against rabies in Europe Vet. Rec. 139 1996 32 35
32. S. Svrcek, R. Ondrejka, Z. Benisek, O.J. Vrtiak, M.A. Selimov, J. Zavadova, A. Durove, J. Suliova, and M. Mad'ar Quantification of residual virulence of the Vnukovo-32/107 rabies virus vaccination strain Vet. Med. (Praha). 40 1995 53 64
33. A. Vos, A. Neubert, O. Aylan, P. Schuster, E. Pommerening, T. Muller, and D.C. Chivatsi An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species Epidem. Infect. 123 1999 165 175
34. A. Vos, A. Neubert, E. Pommerening, T. Muller, L. Dohner, L. Neubert, and K. Hughes Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration J. Gen. Virol. 82 2001 2191 2197
35. A.I. Wandeler Control of wildlife rabies: Europe J.B. Campbell K.M. Charlton Rabies 1988 Kluwer, Academic Publishers Boston 365 380
36. A.I. Wandeler Oral immunization of wildlife G.M. Baer The Natural History of Rabies second ed. 1991 CRC Press Boca Raton 485 503
37. A.I. Wandeler Oral immunization against rabies: afterthoughts and foresight Schweiz. Arch. Tierheilkd. 142 2000 455 462
38. W.G. Winkler, J.H. Shaddock, and L.W. Williams Oral rabies vaccine: evaluation of its infectivity in three species of rodents Am. J. Epidemiol. 104 1976 294 298
39. T.J. Wiktor, R.I. Macfarlan, K.J. Reagan, B. Dietzschold, P.J. Curtis, W.H. Wunner, M.P. Kieny, R. Lathe, J.P. Lecocq, M. Mackett, B. Moss, and H. Koprowski Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene Proc. Natl. Acad. Sci. U.S.A. 81 1984 7194 7198
40. Z.Q. Xiang, G.P. Gao, A. Reyes-Sandoval, Y. Li, J.M. Wilson, and H.C. Ertl Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier J. Virol. 77 2003 10780 10789